Publication | Closed Access

Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells

Cell-based Drug DeliveryNanomedicineEngineeringPolymer-drug ConjugateBrd4 SirnaBreast CancerNano-drug DeliveryTumor TargetingMedicineCell BiologyTumor BiologyBiomolecular Engineering